Rare diseases require radical new funding methods

Devising funding strategies to develop drugs for the treatment of rare diseases remains a challenge as patient groups are often too small

Is accelerating drug trials a good idea?

Acceleration of drug trials offers the potential to bring life-prolonging treatments to patients more quickly, but some physicians warn that research risks being dumbed down

Landmark heart research

Testing new treatments can be the difference between life and death for some patients, as Danny Buckland discovers